According to the Society's bylaws, our Council shall include eight elected Councilors and those members of the Society elected and serving as the President, President-Elect, Secretary-Treasurer, three Vice Presidents, one for each of the following categories of members (physician-in-practice, basic scientist, and clinical scientist), and the immediate Past President of the Society.
Of the eight elected Councilors there shall be a designated seat for each of the three following categories of members: physician-in-practice, basic scientist, and clinical scientist. In addition, the Chief Executive Officer (CEO) of the Society, the Secretary–Treasurer-Elect, when occurring, the Chair of the Nominating Committee shall be ex-officio, non-voting members of Council.
The Chair of the committee designated by Council to handle trainee affairs shall be an ex-officio, voting member of Council. Council may, at its discretion, designate additional ex-officio members as needed to ensure that important membership perspectives are represented.
Dr. Lynnette Nieman, MD is an active clinical investigator, with eleven active protocols and special expertise in disorders of hypercortisolism. She has authored more than 250 publications and sponsored three investigational new drug applications, one of which was licensed in the US and Europe. Dr. Nieman served as an associate editor for the Journal of Clinical Endocrinology and Metabolism and is a past member of the Endocrinology and Metabolism subcommittee of the American Board of Internal Medicine. She has received the NIH Director’s Award, NIH Clinical Teacher of the Year Award and the Endocrine Society’s Distinguished Physician award. She has provided Congressional testimony. She is a past Vice President for Clinical Science of the Endocrine Society and Chaired the Society’s 2012 annual meeting.
Dr. Susan J. Mandel, MD, MPH is a Professor of Medicine and Radiology and Associate Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Pennsylvania where she directs the Endocrine fellowship. After medical school at the College of Physicians and Surgeons, she completed a medical residency at Columbia Presbyterian Medical Center and a fellowship in endocrinology at the Brigham and Women's. At Penn, she oversees a clinical practice with over 23,000 annual visits. Her clinical practice focuses on patients with thyroid neoplasia and she has been recognized for clinical excellence with the Penn Duhring Clinical Specialist award. Her research interests include the use of sonography in the evaluation of patients with thyroid nodules and cancer, and thyroid disease during pregnancy.
Dr. Mandel has served on the writing groups for the American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer and the Management of Thyroid Disease during Pregnancy. She also initiated and directs the Ultrasound workshops for the ATA and Endocrine Society. Dr. Mandel has received the Endocrine Society's Distinguished Educator Award and the H. Jack Baskin Educator Award of the American Association of Clinical Endocrinologists. She is a past Endocrine Society Council member and Vice President Physician-in-Practice, as well as a past President of the Association of Program Directors in Endocrinology, Diabetes, and Metabolism. Dr. Mandel is currently the President-elect of the Endocrine Society.
Henry Kronenberg, MD is Chief of the Endocrine Unit at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School in Boston, MA. There he leads a research group that studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. Dr. Kronenberg's laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone.
An active member of the Endocrine Society for more than two decades, he has served as Vice President, Basic Science, and as a member of the Society’s leadership Council. He also served on a number of Society committees, including the Laureate Awards Committee and Research Affairs Core Committee. Kronenberg has been an editorial board member for the Society’s basic science journals Endocrinology and Molecular Endocrinology. He represented the Society in work with the Federation of American Societies for Experimental Biology (FASEB). His awards and honors include the Society’s Gerald D. Aurbach Award Lecture, the International Research Prize from the Austrian Society for Bone and Mineral Research and the Neuman and Gideon Rodan Mentoring Awards from the American Society for Bone and Mineral Research (ASBMR). He has also served as President of the ASBMR and of the International Bone and Mineral Society.
Richard S. Legro, MD is a Professor in the Department of Obstetrics and Gynecology and Public Health at Pennsylvania State University College of Medicine in Hershey, PA. His research and clinical practice are primarily focused on diagnosis, treatment, and genetic and environmental causes of polycystic ovary syndrome (PCOS), as well as improving infertility diagnosis and treatment. At Penn State Hershey Medical Center, he established one of the first clinics devoted to the treatment of women with PCOS. Dr. Legro has published over 200 articles in peer-reviewed journals and multiple books in the field of reproductive endocrinology, is an Associate Editor for Fertility and Sterility, and is Co-editor in Chief of Seminars in Reproductive Endocrinology. Dr. Legro has been a member of the Endocrine Society since 1998 and has served on the Clinical Guidelines Subcommittee, the Finance and Audit Committee, and the Performance and Compensation Steering Committee.
Howard Baum, MD started his career as a researcher in neuroendocrinology, focusing on growth hormone and IGF-I, but patient care held a greater allure. In 1996, he entered private practice in general endocrinology. During that time, he began his involvement with Endocrine Society governance, bringing the perspective of a clinician to the Clinical Affairs and Scientific and Educational Core Committees and Council. He also participated in teaching programs at UT Southwestern Medical Center as a Clinical Professor. In 2012, Dr. Baum returned to academia, joining the faculty of Vanderbilt University Medical Center where he currently serves as Associate Professor in the Division of Endocrinology. He is Program Leader of the Diabetes and Obesity Clinical Trials Center, Co-Director of the inpatient endocrinology consultation service, and faculty development representative for the junior faculty in the Division. A member since 1996, Dr. Baum has served on the Strategic Planning Committee and several Endocrine Society Task Forces.
Genevieve S. Neal-Perry MD, PhD is an Associate Professor of Obstetrics and Gynecology. She directs the University of Washington Medicine Reproductive Endocrinology and Infertility Center. She has expertise in the treatment of infertility, fertility preservation, recurrent pregnancy loss and the development of procreative management plans for same sex couples and single parents. She is also a leader in the area of medical management of menopause, polycystic ovary syndrome (PCOS), premature loss of ovarian function and other endocrine disorders that affect the function of the hypothalamic-pituitary ovarian axis. Dr. Neal-Perry conducts human and rodent research that is focused on understanding nutritional and environmental factors that affect the age of puberty, ovarian and testicular function, fertility and the age of menopause. She is especially interested in the effect of maternal or paternal environment on fertility of male and female offspring across multiple generations. Dr. Neal-Perry has been a member of the Endocrine Society since 2001 and has served on the Special Programs Committee, the Research Affairs Core Committee, and the ENDO Editorial Board.
Anthony McCall, MD, PhD is a Professor of Medicine in the Division of Diabetes and Metabolism at the University of Virginia (UVA) School of Medicine. He also heads the Clinical Diabetes services at the UVA Health System. In addition, Dr. McCall serves as Medical Director at the Virginia Center for Diabetes Professional Education and the Diabetes Education and Management Program of the UVA Health System. Prior to joining UVA, Dr. McCall was Professor of Medicine at the Oregon Health Sciences University, where he served as Director of Diabetes Research, Director of the VA lipid clinic, and the Co-Director of the High Risk Diabetes clinic. His current clinical research addresses the use of insulin infusions to achieve tight glycemic control with low hypoglycemic risk in patients with cardiovascular surgery and separately work on glucagon dynamics in people at risk for type 1 diabetes. Dr. McCall has been a member of the Endocrine Society since 1984 and has served on the Special Programs Committee and the Annual Meeting Steering Committee.
Daniel Bernard, PhD is a Professor of Pharmacology and Therapeutics and Director of the McGill University Centre for Research in Reproduction and Development. He is also an associate member of the McGill Departments of Physiology, Anatomy and Cell Biology, and Obstetrics and Gynecology, and is a member of the Division of Endocrinology and Metabolism and the Integrated Program in Neuroscience. The Bernard lab investigates molecular mechanisms of pituitary hormone synthesis using in vitro and in vivo approaches. Dr. Bernard has been a member of the Endocrine Society since 2003 and has served on the ENDO and MEND Editorial Boards, the Research Affairs Core Committee, and the Scientific and Educational Programs Core Committee. He has also served on the Advisory Panel on International Outreach, the ENDO Phase I & II Task Forces, the Basic Science Task Force, and the NextGen Task Force. Dr. Bernard is also the Endocrine Society representative on the Science Policy Committee of the Federation of American Societies for Experimental Biology.
Beverly M.K. Biller, M.D. is a faculty member of the Neuroendocrine Unit at The Massachusetts General Hospital, Boston, Massachusetts, and is Professor of Medicine at Harvard Medical School. Dr. Biller has had a longstanding interest in the diagnosis and treatment of pituitary tumors, with a special interest in Cushing’s disease and treatment of growth hormone deficiency in adults, and has published both primary scientific research and clinical guidelines on these topics. She has served as President of the Association of Program Directors of Endocrinology and Metabolism (APDEM) and on the Council of the Growth Hormone Research Society. Dr. Biller has been a member of the Endocrine Society since 1990 and has served as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism, as Chair of the Annual Meeting Steering Committee and as Chair of the Scientific and Educational Programs Core Committee, and has been a member of the Laureate Awards Committee and the Nominating Committee. She serves as Council Liaison to the Endocrine Society Committee on Diversity and Inclusion.
Cesar L. Boguszewski, MD, PhD earned his medical degree from the Federal University of Parana, Curitiba, Brazil, in 1987, where he completed his medical training in Internal Medicine and Endocrinology (1988-1991) and obtained his
degree of Master in Sciences (1993). At the same year, he obtained the National Board Certification in Clinical Endocrinology by the Brazilian Society of Endocrinology and Metabolism (SBEM). Between 1993-1997 he worked at the Research Center for Endocrinology and Metabolism, Sahlgrenska University Hospital, Gothenburg, Sweden, where he obtained a PhD in Endocrinology. He is now Professor of Endocrinology in the Federal University of Parana’s
Department of Internal Medicine, where he served as Vice-Chair (2007-2010) and Chief of the Endocrine Division (SEMPR) of the University Hospital (2005-2014), where he is now responsible for the Neuroendocrinology Unit.
He is Associate Editor for South America for the European Journal of Endocrinology and serves on the editorial board of Archives of Endocrinology and Metabolism. He is chair of the SBEM’s International Committee and was chair of the Executive Committee of the Brazilian Congress of Endocrinology and Metabolism 2014. He served on the Board of Directors of the Pituitary Society 2014-2017 and is member of the Program Organizing Committee (POC)
of the European Congress of Endocrinology (ECE) 2017 in Lisbon, Portugal, and ECE 2018 in Barcelona, Spain. He has authored or coauthored more than 100 journal articles and book chapters, and co-edited a medical book entitled “Pituitary: the master gland”. His main fields of interest are pituitary diseases, obesity, and neuroendocrine regulation of body weight and bone metabolism.
Dr. Alan Dalkin, MD is a professor of medicine in the Division of Endocrinology and Metabolism and is the Vice Chairman for the Department of Medicine at the University of Virginia. In addition to being a clinical educator, he treats patients with a wide variety of endocrine disorders and is an expert in disorders of the bone and mineral. Dr. Dalkin has served as program director of the Endocrine Fellowship Program and is a former chief of the Division of Endocrinology. He serves on the Residency Review Committee, the body that oversees credentialing of all residency and fellowship programs in the United States. Dr. Dalkin has been a member of the Endocrine Society since 1989. He was a member of the ESAP Faculty Group from 2000 to 2011 and chaired the group from 2011-2015.
Anthony Hollenberg, MD is Chief of the Division of Endocrinology, Diabetes and Metabolism and Director of Strategic Research Planning at the Beth Israel Deaconess Medical Center in Boston. He is also the Director of Clinical and Translational Research Training Programs at Harvard Catalyst (the CTSA of Harvard Medical School) and Professor of Medicine at Harvard Medical School. Dr. Hollenberg attended Harvard College (AB) and received his M.D.from the University of Calgary in Canada in 1986. He completed his Internal Medicine residency in 1989 and was chief resident in Medicine in 1990-1991, both at the Beth Israel Hospital. Dr. Hollenberg then completed a fellowship in Endocrinology, Diabetes, and Metabolism at Massachusetts General Hospital in 1994 and was recruited back to Beth Israel to start his academic career. His laboratory focuses on the molecular mechanisms of thyroid hormone action and thyroid gland development. He has served on the Annual Meeting Program Committee at the Endocrine Society and is currently an Editor of Endocrinology. Dr, Hollenberg is currently on the board of directors of the American Thyroid Association and is an elected member of the Association of American Physicians.
Clifford Rosen, MD is the Principal Investigator for the Rosen Musculoskeletal Laboratory at MMCRI and Professor of Medicine at Tufts University School of Medicine. Dr. Rosen has had more than twenty years of continuous NIH funding, first at The Jackson Laboratory and subsequently at Maine Medical Center Research Institute. The Rosen laboratory is studying mesenchymal stem cell fate with particular reference to the switch between pre-adipocytes and pre- osteoblasts. There are currently four NIH funded projects in this laboratory, focused on a central theme of lineage allocation, its biochemical determinants and its alterations in osteoporosis. An R24 on the biology of marrow adiposity is now in its 6th year at NIDDK and Dr. Rosen is the administrative PI for that four center interdisciplinary grant. Dr. Rosen is also the Director of the Physiology Core of the MMCRI Stem Cell COBRE (NIGMS) and oversees whole body and cell phenotyping related to metabolic function. The Rosen laboratory has helped to validate osmium microCT for quantitating marrow fat in mouse samples. His work also includes an R21 on control of osteogenic bioenergetics that is now entering its second year. Dr. Rosen is the past president of the American Society of Bone and Mineral Research. He served as an associate editor at Journal of Clinical Endocrinology and Metabolism, senior associate editor at the Journal of Bone and Mineral Research and Aging Cell. He is currently an Associate Editor at New England Journal of Medicine and eLife. He completed membership on the NIH NIAMS Advisory Council, is a standing member of the FDA Endocrinologic and Metabolic Diseases Advisory Committee.
Jenny Visser, PhD is an Associate Professor at the Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands, where she leads the Metabolism and Reproduction laboratory. She also coordinates and teaches within the medical curriculum at Erasmus MC and is a member of the steering group of the Obesity Center CGG (Centrum Gezond Gewicht), Rotterdam, the Netherlands. Her research group studies sex differences in metabolic function, with a particular emphasis on the contribution of gonadal, adrenal, and gut hormones and growth factors to reproductive and metabolic disorders, using in vitro and in vivo approaches.
Dr. Visser serves as the Basic Science officer for the Special Interest Group Reproductive Endocrinology of European Society of Human Reproduction and Embryology (ESHRE), as associate editor of Human Reproduction, and as editorial board member of Molecular and Cellular Endocrinology. She has also served as the Basic Science co-chair of the Program Organizing Committee (POC) of the European Congress of Endocrinology (ECE) 2015 in Dublin.
Dr. Visser has been a member of the Endocrine Society since 1999 and serves as editorial board member of Endocrinology and the Journal of the Endocrine Society, and as Council Liaison to the Research Affairs Core Committee. She also has served as Basic Science chair of the Annual Meeting Steering Committee (AMSC) for ENDO2016, as member of AMSC for ENDO2012, ENDO2013, and ICE/ENDO2014, and as member the Scientific and Educational Programs Core Committee.
Dr. Carol Hatch Wysham is the Section Head of The Rockwood Center for Diabetes and Endocrinology at Rockwood Clinic in Spokane, WA. She is also Clinical Associate Professor of Medicine in the School of Medicine, University of Washington. Dr. Wysham has been involved in clinical research throughout her career. She has served as the principal investigator for several large-scale clinical trials related to diabetes and its complications/treatments. A member of the Endocrine Society since 1991, she has served as the Chair of the Professional Practice Committee of the ADA (2011, 2012), as co-chair of the ICE/ENDO 2014 and ENDO 2015 Annual Meetings, is Overall Chair of ENDO 2016. She is the recipient of the O.C. Olson Lectureship award (1996), and the Chairman’s Quality Award (2011, 2015).
Lauren Fishbein, MD, PhD is an Assistant Professor in Medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes. She received her bachelor’s degree in Biochemistry from Vassar College and earned her MD, PhD degree from the University of Florida with a PhD in Molecular Genetics. She completed her Internal Medicine Residency at Beth Israel Deaconess Medical Center in Boston and her Endocrinology Fellowship at the University of Pennsylvania. Her research interests are in neuroendocrine tumor genetics with a focus on pheochromocytomas and paragangliomas. Dr. Fishbein has been a member of the Endocrine Society since 2010, and she currently serves as Co-Chair of the Trainee and Career Development Core Committee (TCDCC). As a member of the TCDCC, she was program chair of the Early Career Forum and Career Development Workshops for three years.
Kathryn Martin, MD is an Assistant Professor of Medicine at Harvard Medical School and has been a faculty member and practicing clinician in the Reproductive Endocrine Unit at Massachusetts General Hospital since 1989. In addition to her clinical practice, she has an active teaching role and is involved in the training and supervision of junior faculty members and endocrine fellows. Dr. Martin is also the Senior Deputy Editor for Endocrinology and Patient Education at UpToDate, an online clinical reference for physicians. Her clinical research interests have been in the area of female reproduction, in particular, pathophysiology and management of isolated GnRH deficiency and hypothalamic amenorrhea. Her current clinical focus is female reproduction; she has written and lectured extensively on her particular area of expertise: evaluation and management of menopausal women. Dr. Martin has been active in a number of Endocrine Society committees, and recently completed four years as the Chair of the Clinical Guidelines Subcommittee. She is also the Chair of the Task Force and first author of the Clinical Guideline: Evaluation and Treatment of Hirsutism in Premenopausal Women, first published in 2008, and recently revised and submitted for review. She is currently a member of the Nominating Committee and will serve as its Chair in 2016-2017.
Barbara Byrd Keenan, FASAE, CAEjoined the Endocrine Society as CEO in 2014. Prior to joining the Endocrine Society, Ms. Keenan was the Executive Vice President/CEO of the Institute of Food Technologists and Feeding Tomorrow as well as staff head of the International Food Science Certification Commission. During her decade plus tenure there, the Institute won over 25 awards for education, publishing, advocacy, marketing, design and scientific achievement. 2016 marks her 40th year of association management experience and 30 years of CEO experience, having previously served as CEO with the Hospitality Financial and Technology Professionals International and Community Associations Institute. She also has held senior positions and consulting relationships with the American College of Preventive Medicine, the American College of Cardiology and the American Association of Neurological Surgeons. She is the recipient of the ASAE Key Award — the highest honor in association management and is the 12th woman to receive it since its creation in 1960. She holds a BS and MS degree from Old Dominion University in Virginia, where she was presented with the Distinguished Alumni Award.